40

2.7.4...a trend for a lower incidence of SAEs in Asians categories. g Presented overall for event of interest category. Source: Module 5.3.5.3/TMC278-C904-Ana1-Saf-AE/Disl event by

Download PDF Report

Upload
others
View
3
Download
0

Embed Size (px)

Citation preview

Page 1: 2.7.4...a trend for a lower incidence of SAEs in Asians categories. g Presented overall for event of interest category. Source: Module 5.3.5.3/TMC278-C904-Ana1-Saf-AE/Disl event by

Page 2: 2.7.4...a trend for a lower incidence of SAEs in Asians categories. g Presented overall for event of interest category. Source: Module 5.3.5.3/TMC278-C904-Ana1-Saf-AE/Disl event by

Page 3: 2.7.4...a trend for a lower incidence of SAEs in Asians categories. g Presented overall for event of interest category. Source: Module 5.3.5.3/TMC278-C904-Ana1-Saf-AE/Disl event by

Page 4: 2.7.4...a trend for a lower incidence of SAEs in Asians categories. g Presented overall for event of interest category. Source: Module 5.3.5.3/TMC278-C904-Ana1-Saf-AE/Disl event by

Page 5: 2.7.4...a trend for a lower incidence of SAEs in Asians categories. g Presented overall for event of interest category. Source: Module 5.3.5.3/TMC278-C904-Ana1-Saf-AE/Disl event by

Page 6: 2.7.4...a trend for a lower incidence of SAEs in Asians categories. g Presented overall for event of interest category. Source: Module 5.3.5.3/TMC278-C904-Ana1-Saf-AE/Disl event by

Page 7: 2.7.4...a trend for a lower incidence of SAEs in Asians categories. g Presented overall for event of interest category. Source: Module 5.3.5.3/TMC278-C904-Ana1-Saf-AE/Disl event by

Page 8: 2.7.4...a trend for a lower incidence of SAEs in Asians categories. g Presented overall for event of interest category. Source: Module 5.3.5.3/TMC278-C904-Ana1-Saf-AE/Disl event by

Page 9: 2.7.4...a trend for a lower incidence of SAEs in Asians categories. g Presented overall for event of interest category. Source: Module 5.3.5.3/TMC278-C904-Ana1-Saf-AE/Disl event by

Page 10: 2.7.4...a trend for a lower incidence of SAEs in Asians categories. g Presented overall for event of interest category. Source: Module 5.3.5.3/TMC278-C904-Ana1-Saf-AE/Disl event by

Page 11: 2.7.4...a trend for a lower incidence of SAEs in Asians categories. g Presented overall for event of interest category. Source: Module 5.3.5.3/TMC278-C904-Ana1-Saf-AE/Disl event by

Page 12: 2.7.4...a trend for a lower incidence of SAEs in Asians categories. g Presented overall for event of interest category. Source: Module 5.3.5.3/TMC278-C904-Ana1-Saf-AE/Disl event by

Page 13: 2.7.4...a trend for a lower incidence of SAEs in Asians categories. g Presented overall for event of interest category. Source: Module 5.3.5.3/TMC278-C904-Ana1-Saf-AE/Disl event by

Page 14: 2.7.4...a trend for a lower incidence of SAEs in Asians categories. g Presented overall for event of interest category. Source: Module 5.3.5.3/TMC278-C904-Ana1-Saf-AE/Disl event by

Page 15: 2.7.4...a trend for a lower incidence of SAEs in Asians categories. g Presented overall for event of interest category. Source: Module 5.3.5.3/TMC278-C904-Ana1-Saf-AE/Disl event by

Page 16: 2.7.4...a trend for a lower incidence of SAEs in Asians categories. g Presented overall for event of interest category. Source: Module 5.3.5.3/TMC278-C904-Ana1-Saf-AE/Disl event by

Page 17: 2.7.4...a trend for a lower incidence of SAEs in Asians categories. g Presented overall for event of interest category. Source: Module 5.3.5.3/TMC278-C904-Ana1-Saf-AE/Disl event by

Page 18: 2.7.4...a trend for a lower incidence of SAEs in Asians categories. g Presented overall for event of interest category. Source: Module 5.3.5.3/TMC278-C904-Ana1-Saf-AE/Disl event by

Page 19: 2.7.4...a trend for a lower incidence of SAEs in Asians categories. g Presented overall for event of interest category. Source: Module 5.3.5.3/TMC278-C904-Ana1-Saf-AE/Disl event by

Page 20: 2.7.4...a trend for a lower incidence of SAEs in Asians categories. g Presented overall for event of interest category. Source: Module 5.3.5.3/TMC278-C904-Ana1-Saf-AE/Disl event by

Page 21: 2.7.4...a trend for a lower incidence of SAEs in Asians categories. g Presented overall for event of interest category. Source: Module 5.3.5.3/TMC278-C904-Ana1-Saf-AE/Disl event by

Page 22: 2.7.4...a trend for a lower incidence of SAEs in Asians categories. g Presented overall for event of interest category. Source: Module 5.3.5.3/TMC278-C904-Ana1-Saf-AE/Disl event by

Page 23: 2.7.4...a trend for a lower incidence of SAEs in Asians categories. g Presented overall for event of interest category. Source: Module 5.3.5.3/TMC278-C904-Ana1-Saf-AE/Disl event by

Page 24: 2.7.4...a trend for a lower incidence of SAEs in Asians categories. g Presented overall for event of interest category. Source: Module 5.3.5.3/TMC278-C904-Ana1-Saf-AE/Disl event by

Page 25: 2.7.4...a trend for a lower incidence of SAEs in Asians categories. g Presented overall for event of interest category. Source: Module 5.3.5.3/TMC278-C904-Ana1-Saf-AE/Disl event by

Page 26: 2.7.4...a trend for a lower incidence of SAEs in Asians categories. g Presented overall for event of interest category. Source: Module 5.3.5.3/TMC278-C904-Ana1-Saf-AE/Disl event by

Page 27: 2.7.4...a trend for a lower incidence of SAEs in Asians categories. g Presented overall for event of interest category. Source: Module 5.3.5.3/TMC278-C904-Ana1-Saf-AE/Disl event by

Page 28: 2.7.4...a trend for a lower incidence of SAEs in Asians categories. g Presented overall for event of interest category. Source: Module 5.3.5.3/TMC278-C904-Ana1-Saf-AE/Disl event by

Page 29: 2.7.4...a trend for a lower incidence of SAEs in Asians categories. g Presented overall for event of interest category. Source: Module 5.3.5.3/TMC278-C904-Ana1-Saf-AE/Disl event by

Page 30: 2.7.4...a trend for a lower incidence of SAEs in Asians categories. g Presented overall for event of interest category. Source: Module 5.3.5.3/TMC278-C904-Ana1-Saf-AE/Disl event by

Page 31: 2.7.4...a trend for a lower incidence of SAEs in Asians categories. g Presented overall for event of interest category. Source: Module 5.3.5.3/TMC278-C904-Ana1-Saf-AE/Disl event by

Page 32: 2.7.4...a trend for a lower incidence of SAEs in Asians categories. g Presented overall for event of interest category. Source: Module 5.3.5.3/TMC278-C904-Ana1-Saf-AE/Disl event by

Page 33: 2.7.4...a trend for a lower incidence of SAEs in Asians categories. g Presented overall for event of interest category. Source: Module 5.3.5.3/TMC278-C904-Ana1-Saf-AE/Disl event by

Page 34: 2.7.4...a trend for a lower incidence of SAEs in Asians categories. g Presented overall for event of interest category. Source: Module 5.3.5.3/TMC278-C904-Ana1-Saf-AE/Disl event by

Page 35: 2.7.4...a trend for a lower incidence of SAEs in Asians categories. g Presented overall for event of interest category. Source: Module 5.3.5.3/TMC278-C904-Ana1-Saf-AE/Disl event by

Page 36: 2.7.4...a trend for a lower incidence of SAEs in Asians categories. g Presented overall for event of interest category. Source: Module 5.3.5.3/TMC278-C904-Ana1-Saf-AE/Disl event by

Page 37: 2.7.4...a trend for a lower incidence of SAEs in Asians categories. g Presented overall for event of interest category. Source: Module 5.3.5.3/TMC278-C904-Ana1-Saf-AE/Disl event by

Page 38: 2.7.4...a trend for a lower incidence of SAEs in Asians categories. g Presented overall for event of interest category. Source: Module 5.3.5.3/TMC278-C904-Ana1-Saf-AE/Disl event by

Page 39: 2.7.4...a trend for a lower incidence of SAEs in Asians categories. g Presented overall for event of interest category. Source: Module 5.3.5.3/TMC278-C904-Ana1-Saf-AE/Disl event by

Page 40: 2.7.4...a trend for a lower incidence of SAEs in Asians categories. g Presented overall for event of interest category. Source: Module 5.3.5.3/TMC278-C904-Ana1-Saf-AE/Disl event by

DIVISION OF ANTIVIRAL PRODUCTS (HFD-530 ......Molecular Weight: 366.42 Daltons Molecular Formula: C 22H 18N 6 Structural Formula: TMC278 Dosage Form(s): Route(s) of Administration:

DIVISION OF ANTIVIRAL PRODUCTS (HFD-530 ......Molecular Weight: 366.42 Daltons Molecular Formula: C 22H 18N 6 Structural Formula: TMC278 Dosage Form(s): Route(s) of Administration:

Documents

ADMIRAL - epanorama.net · problem : no vertical solution : check cap c461 3.3mfd at 160 volts brand : fisher model or chassis : pt810 ... replace pot and open filter cap c904: it

Documents

SEMEN CHARACTERISTICS, PRESERVATION AND ITS USE IN ARTIFICIAL INSEMINATION …prr.hec.gov.pk/jspui/bitstream/123456789/8107/1/Bushra... · 2018-07-23 · 5.3.5.3. Sperm viability

SEMEN CHARACTERISTICS, PRESERVATION AND ITS USE IN ARTIFICIAL INSEMINATION …prr.hec.gov.pk/jspui/bitstream/123456789/8107/1/Bushra... · 2018-07-23 · 5.3.5.3. Sperm viability

Documents

48-week primary analysis of trial TMC278-C204: TMC278 demonstrates potent and sustained efficacy in ARV-naïve patients A Pozniak, J Morales-Ramirez, L

48-week primary analysis of trial TMC278-C204: TMC278 demonstrates potent and sustained efficacy in ARV-naïve patients A Pozniak, J Morales-Ramirez, L

Documents

MUNICIPEX WATER SERVICE LINEsandsutilitysales.com/resources/MUNICIPEX_Overview_05.10.pdf · - Produced in SDR9 Copper Tube Sizes (CTS) according to ASTM F876 and AWWA C904 - Compatible

MUNICIPEX WATER SERVICE LINEsandsutilitysales.com/resources/MUNICIPEX_Overview_05.10.pdf · - Produced in SDR9 Copper Tube Sizes (CTS) according to ASTM F876 and AWWA C904 - Compatible

Documents

SECTION 2.6 NONCLINICAL SUMMARY Section 2.6.6 Toxicology … · 2015-05-29 · Toxicology Program.....17 Table 2. Exposure to TMC278 (C max and AUC) in an Oral Single-Dose Study with

SECTION 2.6 NONCLINICAL SUMMARY Section 2.6.6 Toxicology … · 2015-05-29 · Toxicology Program.....17 Table 2. Exposure to TMC278 (C max and AUC) in an Oral Single-Dose Study with

Documents

SM825 2.5SATA 3.0Gb/s E-MLC SSD - Samsung US · military or defense application, ... SM825 2.5"SATA 3.0Gb/s E-MLC SSD (NAND based Solid State Drive) datasheet ... 5.3.5.3 Device error

SM825 2.5SATA 3.0Gb/s E-MLC SSD - Samsung US · military or defense application, ... SM825 2.5"SATA 3.0Gb/s E-MLC SSD (NAND based Solid State Drive) datasheet ... 5.3.5.3 Device error

Documents

Photo pleine page - H. H. Scott 2sa497 r 541 tr608 c904 speaker 2 tr 902 bdiss r 909 2w0-5 pre amp our min amp r631 47k ceoe 0-001 c 609 0-05 r 621 68k r 620 2sc497 m 903 80183 c62

Photo pleine page - H. H. Scott 2sa497 r 541 tr608 c904 speaker 2 tr 902 bdiss r 909 2w0-5 pre amp our min amp r631 47k ceoe 0-001 c 609 0-05 r 621 68k r 620 2sc497 m 903 80183 c62

Documents

Planning and Development of Integrated Summaries of SafetyNov 15, 2006 · Module 5, section 5.3.5.3. ... ¾Availability of data 3. Draft the 2 key planning documents: ... (ISS SAP)

Planning and Development of Integrated Summaries of SafetyNov 15, 2006 · Module 5, section 5.3.5.3. ... ¾Availability of data 3. Draft the 2 key planning documents: ... (ISS SAP)

Documents

Use SharkBite FaST DiSaSSeMBlY own risers · 2017. 4. 13. · standards: NSF 14/61, NSF P171, ASTM F 876, ASTM F 877, CSA B137.5 and AWWA C904. SharkBite PB Couplings are designed

Use SharkBite FaST DiSaSSeMBlY own risers · 2017. 4. 13. · standards: NSF 14/61, NSF P171, ASTM F 876, ASTM F 877, CSA B137.5 and AWWA C904. SharkBite PB Couplings are designed

Documents

CV, 1 CURRICUL UM VITAE · CV,, 3 organisation of Tibotec including the production of regulatory submission documents of medicines in full development phase (TMC114, TMC125, TMC278)

CV, 1 CURRICUL UM VITAE · CV,, 3 organisation of Tibotec including the production of regulatory submission documents of medicines in full development phase (TMC114, TMC125, TMC278)

Documents

First study of repeat dose co-administration of GSK1265744 and TMC278 long-acting parenteral nanosuspensions: pharmacokinetics, safety, and tolerability

First study of repeat dose co-administration of GSK1265744 and TMC278 long-acting parenteral nanosuspensions: pharmacokinetics, safety, and tolerability

Documents

OR E N FÜ R S CH ANKANLAGENOF -C904 / OF-C90-10 O M P … · 3 Your international partner for compressors and vacuum pumps. The company „PLANET-AIR“ looks back on over 50 years

OR E N FÜ R S CH ANKANLAGENOF -C904 / OF-C90-10 O M P … · 3 Your international partner for compressors and vacuum pumps. The company „PLANET-AIR“ looks back on over 50 years

Documents

TMC278 Update, 30th January 2009 C204 data ECHO and THRIVE - Phase III studies New TMC278 formulations Peter Williams Tibotec BVBA, Mechelen, Belgium

TMC278 Update, 30th January 2009 C204 data ECHO and THRIVE - Phase III studies New TMC278 formulations Peter Williams Tibotec BVBA, Mechelen, Belgium

Documents

AXM - Multidos · vestel project name : a3 sch name : drawn by : t. sht: s41 s40 1 tp47 1 tp48 tun_scl r29 47r tun_sda tun_sda c34 50v 33pf tun_scl active_ant_supply c904 100nf 10v

AXM - Multidos · vestel project name : a3 sch name : drawn by : t. sht: s41 s40 1 tp47 1 tp48 tun_scl r29 47r tun_sda tun_sda c34 50v 33pf tun_scl active_ant_supply c904 100nf 10v

Documents

PMC-R30L - ПромэлектроникаSCHEMATIC DIAGRAM — POWER SUPPLY SECTION — ... POWER TRANSFORMER D903 D904 04 D905 F901 AC IN CNP901 CNP902 C906 C905 C904 F902 D902 C902

PMC-R30L - ПромэлектроникаSCHEMATIC DIAGRAM — POWER SUPPLY SECTION — ... POWER TRANSFORMER D903 D904 04 D905 F901 AC IN CNP901 CNP902 C906 C905 C904 F902 D902 C902

Documents

5.3.5.3 Lab - Área de Trabalho Remota e Assistência Remota ...€¦ · 5.3.5.3 Lab - Área de Trabalho Remota e Assistência Remota no Windows Vista Introdução Imprima e preencha

5.3.5.3 Lab - Área de Trabalho Remota e Assistência Remota ...€¦ · 5.3.5.3 Lab - Área de Trabalho Remota e Assistência Remota no Windows Vista Introdução Imprima e preencha

Documents

Agenda Update on Darunavir: Perry Mohammed Update on Etravirine: Rekha Sinha Update on TMC278: Peter Williams Update on TMC207: Karel De Beule

Agenda Update on Darunavir: Perry Mohammed Update on Etravirine: Rekha Sinha Update on TMC278: Peter Williams Update on TMC207: Karel De Beule

Documents

VIETMOBILE - Android Free File · 2020. 7. 23. · C944 C971 C1802 C904 C951 C901 C1825 R1836 R1835 R1834 R1833 R1828 E1804 E1803 R3113 ANT3100 C3203 C3204 C3200 R3003 U3200 R3203

VIETMOBILE - Android Free File · 2020. 7. 23. · C944 C971 C1802 C904 C951 C901 C1825 R1836 R1835 R1834 R1833 R1828 E1804 E1803 R3113 ANT3100 C3203 C3204 C3200 R3003 U3200 R3203

Documents

TE-905 service manual - TDJ service... · 2017. 8. 6. · c903 zd902 nc c904 nc zd903 104 c905 r948 r9471k r946 1k r945 r9441k r943 1k tvs901 r949 10 c906 10uf c907 104 r950 nc r951

TE-905 service manual - TDJ service... · 2017. 8. 6. · c903 zd902 nc c904 nc zd903 104 c905 r948 r9471k r946 1k r945 r9441k r943 1k tvs901 r949 10 c906 10uf c907 104 r950 nc r951

Documents

Background TMC278, a next-generation NNRTI, has demonstrated in-vitro activity against wild-type and NNRTI-resistant isolates 1 48-week results from an

Background TMC278, a next-generation NNRTI, has demonstrated in-vitro activity against wild-type and NNRTI-resistant isolates 1 48-week results from an

Documents

TMC278 long acting – a parenteral nanosuspension ... · René Verloes Tibotec BVBA Generaal De Wittelaan L11 B3 B-2800 Mechelen Belgium rverloes@tibbe.JNJ.com TMC278 long acting

TMC278 long acting – a parenteral nanosuspension ... · René Verloes Tibotec BVBA Generaal De Wittelaan L11 B3 B-2800 Mechelen Belgium [email protected] TMC278 long acting

Documents

Use SharkBite FaST DiSaSSeMBlY own risers · NSF P171, ASTM F 876, ASTM F 877, CSA B137.5 and AWWA C904. The SharkBite® tubing with oxygen barrier is approved for use in all model

Use SharkBite FaST DiSaSSeMBlY own risers · NSF P171, ASTM F 876, ASTM F 877, CSA B137.5 and AWWA C904. The SharkBite® tubing with oxygen barrier is approved for use in all model

Documents

CHAPTER PAGE HHSC UNIFORM MANAGED CARE 5.3.5.3 1 …...Description and Appeal Process for Edit Numbers E104, E110, E111 and E116. “Data Certification Form” is modified to provide

CHAPTER PAGE HHSC UNIFORM MANAGED CARE 5.3.5.3 1 …...Description and Appeal Process for Edit Numbers E104, E110, E111 and E116. “Data Certification Form” is modified to provide

Documents

[[4-[[4-[(E -2- Cyanoethenyl TMC278/Rilpivirine · Article Journal of Medicinal Chemistry, 2009, Vol. 52, No. 19 5897 molecules per particle.21,23 Oral bioavailability properties

[[4-[[4-[(E -2- Cyanoethenyl TMC278/Rilpivirine · Article Journal of Medicinal Chemistry, 2009, Vol. 52, No. 19 5897 molecules per particle.21,23 Oral bioavailability properties

Documents